Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 3
Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform
Marie Morfouace, Marie Morfouace, Silvia Novello, A. Stevovic, C. Dooms, Urška Janžič, Thierry Berghmans, Rafal Dziadziuszko, T. Gorlia, Enriqueta Felip, Benjamin Besse
Izvirni znanstveni članek
Oznake: malignosti;pljučni rak;malignancies;lung cancer;
Access to a comprehensive molecular alteration screening is patchy in Europe and quality of the molecular analysis varies. SPECTAlung was created in 2015 as a pan-European screening platform for patients with thoracic malignancies. Here we report the results of almost 4 years of prospective molecula ...
Leto: 2022 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Real-world experience in treatment of patients with non-small-cell lung cancer with BRAF or cMET exon 14 skipping mutations
Urška Janžič, Walid Shalata, Katarzyna Szymczak, Rafal Dziadziuszko, Marko Jakopović, Giannis Mountzios, Adam Płużański, António Araújo, Andriani Charpidou, Abed Agbarya
Izvirni znanstveni članek
Oznake: nedrobnocelični pljučni rak;mutacija BRAF V600;podatki iz resničnega življenja;tarčna terapija;zdravljenje prvega reda;non-small-cell lung cancer;BRAF V600 mutation;cMET exon 14 skipping mutation;real-world data;targeted therapy;first-line therapy;
BRAF and cMET exon 14 skipping are rare mutations of NSCLC. The treatment sequence in these cases for the first and second line is not clear. An international registry was created for patients with advanced NSCLC harboring BRAF or cMET exon 14 skipping mutations, diagnosed from January 2017 to June ...
Leto: 2023 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
NSCLC molecular testing in Central and Eastern European countries
Ales Ryška, Peter Berzinec, Luka Brčić, Tanja Čufer, Rafal Dziadziuszko, Maya Gottfried, Ilona Kovalszky, Włodzimierz Olszewski, Buge Oz, Lukas Plank, József Tímár
Izvirni znanstveni članek
Oznake: EGFR mutations;ALK rearrangements;Central Europe;Eastern Europe;Srednja Evropa;Vzhodna Evropa;
Background: The introduction of targeted treatments for subsets of non-small cell lung cancer (NSCLC) has highlighted the importance of accurate molecular diagnosis to determine if an actionable genetic alteration is present. Few data are available for Central and Eastern Europe (CEE) on mutation ra ...
Leto: 2018 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Št. zadetkov: 3
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: